Board MeetingOutcome of Board Meeting
Morepen Labs' board met on Feb 10, 2026, and approved consolidated financial results for the quarter and nine months ended Dec 31, 2025. Q3 revenue was ₹487.97 Cr with a ₹27.50 Cr profit.
Morepen Laboratories LimitedMOREPENLAB · Filed with the exchange
For the nine months, revenue hit ₹1333.82 Cr, with profit at ₹79.95 Cr.
No comments yet. Be the first.